The Role of Inflammatory Gene Polymorphisms in Severe COVID-19: a Review

Overview

Journal Virol J

Publisher Biomed Central

Specialty Microbiology

Date 2024 Dec 20

PMID 39707400

Authors

Jia Qi Yip

Adrian Oo

Yan Ling Ng

Kim Ling Chin

Kim-Kee Tan

Justin Jang Hann Chu

Sazaly AbuBakar

Nurhafiza Zainal

Affiliations

Soon will be listed here.

Abstract

The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has profoundly impacted global healthcare systems and spurred extensive research efforts over the past three years. One critical aspect of the disease is the intricate interplay between the virus and the host immune response, particularly the role of inflammatory gene expression in severe COVID-19. While numerous previous studies have explored the role of genetic polymorphisms in COVID-19, research specifically focusing on inflammatory genes and their associations with disease severity remains limited. This review explores the relationship between severe COVID-19 outcomes and genetic polymorphisms within key inflammatory genes. By investigating the impact of genetic variations on immune responses, which include cytokine production and downstream signalling pathways, we aim to provide a comprehensive overview of how genetic polymorphisms contribute to the variability in disease presentation. Through an in-depth analysis of existing literature, we shed light on potential therapeutic targets and personalized approaches that may enhance our understanding of disease pathogenesis and treatment strategies.

Citing Articles

Genetics of Long COVID: Exploring the Molecular Drivers of Persistent Pulmonary Vascular Disease Symptoms.

Ayyoub S, Dhillon N, Tura-Ceide O Infect Dis Rep. 2025; 17(1).

PMID: 39997467 PMC: 11855385. DOI: 10.3390/idr17010015.

References

Zaim S, Chong J, Sankaranarayanan V, Harky A . COVID-19 and Multiorgan Response. Curr Probl Cardiol. 2020; 45(8):100618. PMC: 7187881. DOI: 10.1016/j.cpcardiol.2020.100618. View

Gorham J, Moreau A, Corazza F, Peluso L, Ponthieux F, Talamonti M . Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis. PLoS One. 2020; 15(12):e0244628. PMC: 7774924. DOI: 10.1371/journal.pone.0244628. View

Zhao J, Saleh A, Crooke S . SIDT2 Inhibits Phosphorothioate Antisense Oligonucleotide Activity by Regulating Cellular Localization of Lysosomes. Nucleic Acid Ther. 2022; 33(2):108-116. DOI: 10.1089/nat.2022.0055. View

Bozovic I, Perovic V, Basta I, Peric S, Stevic Z, Popadic D . Cytokine Gene Polymorphisms in Patients with Chronic Inflammatory Demyelinating Polyneuropathy. Cells. 2023; 12(16). PMC: 10453148. DOI: 10.3390/cells12162033. View

Chamnanphon M, Pongpanich M, Suttichet T, Jantarabenjakul W, Torvorapanit P, Putcharoen O . Host genetic factors of COVID-19 susceptibility and disease severity in a Thai population. J Hum Genet. 2022; 67(5):295-301. PMC: 8748005. DOI: 10.1038/s10038-021-01009-6. View

Crozier W . Comparative electrophoretic examination of the two European species of angler-fish (Lophiidae): Lophius piscatorius (L.) and Lophius budegassa (Spinola) and assessment of their genetic relationship. Comp Biochem Physiol B. 1988; 90(1):95-8. DOI: 10.1016/0305-0491(88)90042-9. View

Barton L, Duval E, Stroberg E, Ghosh S, Mukhopadhyay S . COVID-19 Autopsies, Oklahoma, USA. Am J Clin Pathol. 2020; 153(6):725-733. PMC: 7184436. DOI: 10.1093/ajcp/aqaa062. View

Rarani F, Rashidi B, Jafari Najaf Abadi M, Hamblin M, Hashemian S, Mirzaei H . Cytokines and microRNAs in SARS-CoV-2: What do we know?. Mol Ther Nucleic Acids. 2022; 29:219-242. PMC: 9233348. DOI: 10.1016/j.omtn.2022.06.017. View

Shen X, Geng R, Li Q, Chen Y, Li S, Wang Q . ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct Target Ther. 2022; 7(1):83. PMC: 8914143. DOI: 10.1038/s41392-022-00919-x. View

10.

Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P . Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020; 383(16):1522-1534. PMC: 7315890. DOI: 10.1056/NEJMoa2020283. View

11.

Khan A, Sergi C . SAMHD1 as the Potential Link Between SARS-CoV-2 Infection and Neurological Complications. Front Neurol. 2020; 11:562913. PMC: 7546029. DOI: 10.3389/fneur.2020.562913. View

12.

Garrafa E, Imberti L, Tiberio G, Prandini A, Giulini S, Caimi L . Heterogeneous expression of toll-like receptors in lymphatic endothelial cells derived from different tissues. Immunol Cell Biol. 2010; 89(3):475-81. DOI: 10.1038/icb.2010.111. View

13.

Zhang C, Wu Z, Li J, Zhao H, Wang G . Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020; 55(5):105954. PMC: 7118634. DOI: 10.1016/j.ijantimicag.2020.105954. View

14.

da Silva R, de Sarges K, Cantanhede M, da Costa F, Dos Santos E, Rodrigues F . Thrombophilia and Immune-Related Genetic Markers in Long COVID. Viruses. 2023; 15(4). PMC: 10143911. DOI: 10.3390/v15040885. View

15.

Chen J, Chen J, Lei Z, Zhang F, Zeng L, Wu X . Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer's disease. Transl Psychiatry. 2023; 13(1):396. PMC: 10725492. DOI: 10.1038/s41398-023-02692-z. View

16.

Njenga M, Dawa J, Nanyingi M, Gachohi J, Ngere I, Letko M . Why is There Low Morbidity and Mortality of COVID-19 in Africa?. Am J Trop Med Hyg. 2020; 103(2):564-569. PMC: 7410455. DOI: 10.4269/ajtmh.20-0474. View

17.

Mackay I, Arden K . MERS coronavirus: diagnostics, epidemiology and transmission. Virol J. 2015; 12:222. PMC: 4687373. DOI: 10.1186/s12985-015-0439-5. View

18.

Haas U, Sczakiel G, Laufer S . MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3'-UTR via altered RNA structure. RNA Biol. 2012; 9(6):924-37. PMC: 3495750. DOI: 10.4161/rna.20497. View

19.

Leal V, Paulino L, Cambui R, Zupelli T, Yamada S, Oliveira L . A common variant close to the "tripwire" linker region of NLRP1 contributes to severe COVID-19. Inflamm Res. 2022; 72(10-11):1933-1940. PMC: 9684769. DOI: 10.1007/s00011-022-01670-3. View

20.

Aribi M, Mennechet F, Touil-Boukoffa C . Editorial: The role of vitamin D as an immunomodulator. Front Immunol. 2023; 14:1186635. PMC: 10086413. DOI: 10.3389/fimmu.2023.1186635. View